Rolipram does not normalize very long-chain fatty acid levels in adrenoleukodystrophy protein-deficient fibroblasts and mice

Journal of Inherited Metabolic Disease

Volumn 23, Issue 6, 2000, Pages 615-624

  Netik, A ^a   Hobel, A ^b   Rauschka, H ^a   Molzer, B ^b   Forss Petter, S ^a   Berger, J ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; DIMETHYL SULFOXIDE; ROLIPRAM; VERY LONG CHAIN FATTY ACID;

ADRENAL GLAND; ADRENOLEUKODYSTROPHY; ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASSAY; BIOACCUMULATION; BLOOD LEVEL; CONTROLLED STUDY; DEGENERATIVE DISEASE; DEMYELINATION; DIET; DISEASE SEVERITY; DRUG MECHANISM; DRUG PURITY; DRUG STRUCTURE; FATTY ACID OXIDATION; FIBROBLAST; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MALE; MOUSE; NERVOUS SYSTEM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PEROXISOME; PROTEIN DEFICIENCY; TISSUE LEVEL; X CHROMOSOME LINKED DISORDER;

ADRENOLEUKODYSTROPHY; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CELL LINE, TRANSFORMED; FATTY ACIDS; FIBROBLASTS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; PHOSPHODIESTERASE INHIBITORS; ROLIPRAM; SIMIAN VIRUS 40;

EID: 0033797403     PISSN: 01418955     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005686114356     Document Type: Article

References (25)

1. Cotransfection of granulosa cells with simian virus 40 and Ha-RAS oncogene generates stable lines capable of induced steroidogenesis
2. Rolipram, a specific type IV phosphodiesterase inhibitor, is a potent inhibitor of HIV-1 replication
3. X-linked adrenoleukodystrophy
4. Peroxisomal very long chain fatty acid β-oxidation activity is determined by the level of adrenoleukodystrophy protein (ALDP) expression
5. A multicenter double-blind study of three different doses of the new cAMP-phosphodiesterase inhibitor rolipram in patients with major depressive disorder
6. A simple method for the isolation and purification of total lipids from animal tissues
7. Targeted inactivation of the X-linked adrenoleukodystrophy gene in mice
8. Rolipram in major depressive disorder: Result of a double-blind comperative study with imipramin
9. Regulation of IL 15-stimulated TNF-α production by rolipram
10. Gene redundancy and pharmacological gene therapy: Implications for X-linked adrenoleukodystrophy
11. Type 4 cyclic adenosine monophosphate phosphodiesterases as a therapeutic target in chronic lymphocytic leukemia
12. Measurements of saturated very long chain fatty acids in plasma
13. X-linked adrenoleukodystrophy
14. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters
15. The phosphodiesterase IV inhibitor rolipram in vitro reduces the number of MBP-reactive IFN- and TNF-mRNA expressing blood mononuclear cells in patients with multiple sclerosis
16. Adrenoleukodystrophy-related protein can compensate functionally for adrenoleukodystrophy protein deficiency (X-ALD): Implications for therapy
17. Therapy for X-adrenoleukodystrophy: Normalization of very long chain fatty acids and inhibition of induction of cytokines by cAMP
18. In-patient major depression: Is rolipram as effective as amitryptiline?
19. Anti-inflammatory activity of phosphodiesterase (PDE)-IV inhibitors in acute and chronic models of inflammation
20. Lovastatin and sodium phenylacetate normalize the levels of very long chain fatty acids in skin fibroblasts of X-adrenoleukodystrophy
21. Lovastatin for X-linked adrenoleukodystrophy
22. The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis
23. Effects of rolipram on responses to acute and chronic exposure in monkeys
24. The second-messenger dysbalance hypotheses of affective disorders
25. Altered expression of ALDP in X-linked adrenoleukodystrophy